The molecular biology section of the Hereditary Non-Polyposis Colorectal Cancer study
group-Germany, instituted a multicenter study to test the reliability and quality of microsatellite …

The aim of this article is to present updated guidelines for the use of serum, tissue and faecal
markers in colorectal cancer (CRC). Lack of specificity and sensitivity preclude the use of …

Background Most patients with path_MMR gene variants (Lynch syndrome (LS)) now survive
both their first and subsequent cancers, resulting in a growing number of older patients with …

Objective Estimates of cancer risk and the effects of surveillance in Lynch syndrome have
been subject to bias, partly through reliance on retrospective studies. We sought to establish …

The clinical classification of hereditary sequence variants identified in disease-related genes
directly affects clinical management of patients and their relatives. The International Society …

Purpose Pathogenic variants affecting MLH1, MSH2, MSH6, and PMS2 cause Lynch syndrome
and result in different but imprecisely known cancer risks. This study aimed to provide …

The CGG repeat in the 5′ untranslated region of the fragile X mental retardation 1 gene (FMR1)
exhibits remarkable instability upon transmission from mothers with premutation alleles. …

Importance Mitochondrial disorders have emerged as a common cause of inherited disease,
but their diagnosis remains challenging. Multiple respiratory chain complex defects are …

Background Lynch syndrome is caused by germline mutations in MSH2, MLH1, MSH6, and
PMS2 mismatch-repair genes and leads to a high risk of colorectal and endometrial cancer. …

Purpose Patients with Lynch syndrome are at high risk for colon and endometrial cancer,
but also at an elevated risk for other less common cancers. The purpose of this retrospective …